Shanghai Henlius Biotech Inc.

04/20/2021 | Press release | Distributed by Public on 04/20/2021 06:12

VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL FOR RECOMBINANT ANTI-VEGF HUMANISED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION HLX04-O FOR THE TREATMENT OF WET[...]